68Ga-pentixafor PET/CT | 18F-FDG PET/CT | |||||
---|---|---|---|---|---|---|
∆TLUCXCR4% | ∆MTVCXCR4% | ∆SUVpeak% | ∆TLGFDG% | ∆MTVFDG% | ∆SUVpeak% | |
Clinical response | ||||||
r (95% CI) | − 0.780 (− 0.923 to − 0.446) | − 0.761 (− 0.916 to − 0.408) | − 0.725 (− 0.902 to − 0.339) | − 0.411 (− 0.763 to 0.129) | − 0.411 (− 0.763 to 0.129) | − 0.357 (− 0.735 to 0.190) |
p | 0.0006* | 0.001* | 0.0022* | 0.1283 | 0.1283 | 0.1910 |
∆M-pro% | ||||||
r (95% CI) | 0.821 (0.532 to 0.938) | 0.796 (0.478 to 0.929) | 0.724 (0.337 to 0.902) | 0.439 (− 0.0942 to 0.777) | 0.439 (− 0.0942 to 0.777) | 0.447 (− 0.0846 to 0.781) |
p | 0.0002* | 0.0004* | 0.0023* | 0.1013 | 0.1013 | 0.0948 |
∆IgM% | ||||||
r (95% CI) | 0.764 (0.414 to 0.917) | 0.739 (0.365 to 0.908) | 0.654 (0.212 to 0.873) | 0.469 (− 0.0573 to 0.791) | 0.469 (− 0.0573 to 0.791) | 0.430 (− 0.106 to 0.772) |
p | 0.0009* | 0.0016* | 0.0082* | 0.0780 | 0.0780 | 0.1097 |